Featured Content

Named Patient Use Program for TEPEZZA® (teprotumumab-trbw)

Read More

Our Commitment to Anti-Racism

Read More

Statement on Horizon’s Acquisition of Viela Bio, Inc.

Read More

Statement on TEPEZZA® (teprotumumab-trbw) Availability

Read More

Featured Videos

Corporate Brochure

Corporate Brochure

Fact Sheets & Downloads

Media Inquiries

For U.S. media inquiries, contact:
Geoff Curtis
Senior Vice President, Corporate Affairs
media@horizontherapeutics.com
+1 (888) 506-2562

For EU media inquiries, contact:
Ray Gordon
Managing Director
ray@gordonmrm.ie
+353 (87) 2417373